MedPath
NMPA Approval

Oxybuprocaine Hydrochloride Eye Drops

国药准字H21023202

January 8, 2021

Drug Information

盐酸奥布卡因滴眼液

滴眼剂

1ml:4mg;5ml:20mg

化学药品

January 8, 2021

Company Information

Applicant Company

Manufacturing Company

沈阳市新民经济开发区东大营

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸奥布卡因滴眼液 - NMPA 批准文号 | MedPath